| For: | Milosevic I, Russo E, Vujovic A, Barac A, Stevanovic O, Gitto S, Amedei A. Microbiota and viral hepatitis: State of the art of a complex matter. World J Gastroenterol 2021; 27(33): 5488-5501 [PMID: 34588747 DOI: 10.3748/wjg.v27.i33.5488] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i33/5488.htm |
| Number | Citing Articles |
| 1 |
Lindsey M. Williams, Shijie Cao. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches. Pharmacology & Therapeutics 2024; 256 doi: 10.1016/j.pharmthera.2024.108605
|
| 2 |
Huayu Guan, Xiang Zhang, Ming Kuang, Jun Yu. The gut–liver axis in immune remodeling of hepatic cirrhosis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.946628
|
| 3 |
Javier Orozco-Cordoba, Camila Mazas, Gisela Du Pont, Edmundo Lamoyi, Graciela Cárdenas, Nora A. Fierro. Viral Biology and Immune Privilege in the Development of Extrahepatic Manifestations During Hepatitis E Virus Infection. Viral Immunology 2023; 36(10) doi: 10.1089/vim.2023.0096
|
| 4 |
Satyam Yadav, Ranjeet Kumar. Gut Microbiota and the Gut-liver Axis in Hepatocellular Carcinoma: A Comprehensive Review of Pathogenesis and Therapeutic Strategies. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(17) doi: 10.2174/0118715206364200250304034753
|
| 5 |
Xiang-Yan Liu, Jian-Fang Lu, Zhuo-Yi Wang, Shu-Sen Zheng. Non-invasive diagnostic biomarkers of viral hepatitis based on multi-omics technology: Recent advances and challenges. Hepatobiliary & Pancreatic Diseases International 2026; 25(1) doi: 10.1016/j.hbpd.2025.10.010
|
| 6 |
Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Răzvan Cătălin Popescu, Mihaela Pundiche Butcaru, Eugen Dumitru, Sorin Rugină, Cristina Tocia. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052472
|
| 7 |
Nevena Todorovic, Serena Martinelli, Giulia Nannini, Ralf Weiskirchen, Amedeo Amedei. Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development. International Journal of Molecular Sciences 2024; 25(24) doi: 10.3390/ijms252413510
|
| 8 |
Shuyu Liu, Xilan Yang. Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1140126
|
| 9 |
Camilla Tincati, Monica Ficara, Francesca Ferrari, Matteo Augello, Laura Dotta, Claudia Tagliabue, Alfredo Diana, Vittoria Camelli, Lorenzo Iughetti, Raffaele Badolato, Monica Cellini, Giulia Marchetti. Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus. AIDS 2022; 36(14) doi: 10.1097/QAD.0000000000003324
|
| 10 |
Mariam Ghozzi, Amani Mankai, Fatma Mechi, Zeineb Ben Chedly, Ouafa Kallala, Sarra Melayah, Abdelhalim Trabelsi, Ibtissem Ghedira. High frequency of anti-Saccharomyces cerevisiae antibodies in chronic hepatitis C. Arab Journal of Gastroenterology 2024; 25(4) doi: 10.1016/j.ajg.2024.07.013
|
| 11 |
Cheng Guo, Boyang Yi, Jianyong Wu, Jiahai Lu. The microbiome in post-acute infection syndrome (PAIS). Computational and Structural Biotechnology Journal 2023; 21 doi: 10.1016/j.csbj.2023.08.002
|
| 12 |
Alejandro Borrego-Ruiz, Juan J. Borrego. The Gut Microbiome in Enteric Viral Infections: Underlying Mechanisms and Therapeutic Approaches. Microorganisms 2025; 13(10) doi: 10.3390/microorganisms13102247
|
| 13 |
Anissa Idrissa Abdoulaye, Babacar Mbaye, Reham Magdy Wasfy, Louis Carmarans, Mamadou Beye, Claudia Andrieu, Sofiane Bakour, Aïcha Hamieh, Nicholas Armstrong, Patrick Borentain, Fadi Bittar, Stéphane Ranque, Jean-Marc Rolain, Gregory Dubourg, Jean-Christophe Lagier, Maryam Tidjani Alou, René Gerolami, Matthieu Million.
In vitro
study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseases
. Gut Microbes Reports 2026; 3(1) doi: 10.1080/29933935.2026.2664983
|
| 14 |
Gursimran Singh, Shazia Ansari, Satyam Yadav, Khadga Raj Aran. Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications. Microbial Pathogenesis 2026; 211 doi: 10.1016/j.micpath.2025.108273
|
| 15 |
|
| 16 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 17 |
Xing Yang, Huanzhuo Mai, Jie Zhou, Zhuoxin Li, Qing Wang, Liuyan Lan, Fang Lu, Xiping Yang, Baodong Guo, Li Ye, Ping Cui, Hao Liang, Jiegang Huang. Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1119875
|
| 18 |
Ioannis Alexandros Charitos, Angelo Michele Inchingolo, Laura Ferrante, Francesco Inchingolo, Alessio Danilo Inchingolo, Francesca Castellaneta, Antonella Cotoia, Andrea Palermo, Salvatore Scacco, Gianna Dipalma. The Gut Microbiota’s Role in Neurological, Psychiatric, and Neurodevelopmental Disorders. Nutrients 2024; 16(24) doi: 10.3390/nu16244404
|
| 19 |
Kainat Raziq, Syed Qaswar Ali Shah, Mirza Naveed Shahzad, Umm E. Ummara, Mishal Subhan, Muhammad Muzammil Nazir. The gut–liver–virus axis in hepatitis B and C: microbiota, immunometabolism, and exosome-mediated therapeutic opportunities. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(5) doi: 10.1007/s00210-025-04856-8
|